[ORGANIZATION]
denecimig
Featured in 2 tracked stories · first seen
Situations
FDA review delay for Novo Nordisk hemophilia drug
2 clusters · 6 sources · last updated
Latest: Novo Nordisk Denecimig review extended by FDA
The U.S. Food and Drug Administration (FDA) has extended its review of Novo Nordisk’s experimental drug denecimig, a bispecific antibody intended to treat hemophilia A. Novo Nordisk reported that the delay is due to on